# Biobot Surgical Pte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biobot-surgical-pte

- Industry: Medical Devices & Equipment
- Headquarters: Singapore, Singapore
- Website: www.biobotsurgical.com
- Total disclosed funding: $34M
- Latest round: Series C (Apr 15, 2026)
- Investors on record: 3

## About

Founded in 2007 by Sim Giok Lak and based in Singapore, Biobot Surgical Pte. Ltd. is a health tech company that focuses on robotic-assisted percutaneous surgical systems. The company uses technology to improve diagnostic and treatment accuracy for patients. As of 2022, Sim Kok Hwee is the CEO of the company. The company provides iSR’obot Mona Lisa, urofusion software, urobiopsy software, easel bed mount, and a biopsy kit. The firm's iSR’obot Mona Lisa is a robotic system that performs transperineal MRI-ultrasound fusion targeted prostate biopsy. In April 2026, Biobot Surgical Pte Ltd raised USD 15.5 million in series C funding led by ClavystBio, with participation from Temasek Holdings, Kupa, Jiayu Capital, Ptsm Holdings Pte. Ltd. and ZIG Ventures.

The organization's iSR’obot Mona Lisa 2.0 is a robotic-assisted percutaneous surgical system that allows clinicians to plan and position needles during image-guided diagnostic and interventional prostate procedures. Biobot Surgical's features include robotic needle guide positioning and depth control, prostate stability with ultrasound probe sheath, dual Cone technology, automated yet flexible biopsy planning, and elastic MRI-ultrasound fusion. The company will use the April 2026 funding to accelerate growth and scale its robotic surgical solutions.

## Funding rounds

- Series C, Apr 15, 2026, $16M — ZIG Ventures, ClavystBio
- Series B, Mar 17, 2025, $6.4M — ZIG Ventures, Astrid Hill Investment Pte Ltd
- Series B, Jun 28, 2024, $12M — ZIG Ventures

## Investors

- ZIG Ventures (https://capitalatlas.ai/funds/zig-ventures) — Series B, Series C
- Astrid Hill Investment Pte Ltd — Series B
- ClavystBio (https://capitalatlas.ai/funds/clavystbio) — Series C
